BY: MARI EDLIN

Interferon-free solutions expected soon.

BY: MARI EDLIN

Plans can help reduce prescription drug abuse by advocating appropriate use.

BY: MARI EDLIN

Despite front-end scrutiny, payers seek audit process to improve high-cost specialty pharmacies.

BY: MARI EDLIN

Part D program exceeds industry expectations

BY: MARI EDLIN

Oncology pathways can lead to quality programs and more cost-effective care for cancer patients.

BY: MARI EDLIN

Are drug-price guarantees here to stay?

BY: MARI EDLIN

Prior authorization doesn't have to rely on paper forms and telephone requests.

BY: MARI EDLIN

California has adopted some managed care principles, hoping to achieve accessible, cost-effective care.

BY: MARI EDLIN

This year might be remembered for its generic pipeline, with as many as 37 drugs coming off patent.

BY: MARI EDLIN

FDA-approved orphan drugs prompt plans to identify members.